Le Lézard
Classified in: Health
Subjects: WOM, CSR

Sientra Supports Reconstructive Breast Patients with Launch of Full Circletm Grant Program and Revolutionary Portfolio of Tissue Expanders

SANTA BARBARA, Calif., Oct. 6, 2017 /PRNewswire/ -- Sientra, Inc. (NASDAQ: SIEN), a medical aesthetics company, today announced that it is Expanding What's Possible through the launch of Full Circletm, a first-in-kind annual charitable program to support research of breast cancer prevention, detection, and treatment and elevate awareness among the breast cancer and breast reconstruction community. As part of the Full Circletm program, Sientra will donate a portion of every tissue expander sale to breast cancer support and awareness initiatives, thereby giving every impacted breast reconstruction patient a direct influence on the furthering of breast cancer research, prevention and awareness. 

"We hear stories every day about how education and access to options help women reconstruct their bodies and their lives after difficult journeys, but we realize new sources of funding are critical," said Dr. Kamakshi R. Zeidler, founder of Aesthetx, a premier plastic and aesthetic surgery practice in Northern California. "I am touched by what Sientra is doing to honor this special group of patients and am thrilled that they are supporting the work of nonprofits and research organizations. This is truly an emblem of hope for breast cancer aid and research."

The program will issue a call for applicants in early 2018, and will provide grants for up to three nonprofit organizations or research projects. Full Circletm grants are open to any U.S.-based breast cancer research organization, groups providing funding for breast reconstruction, scientific research groups focused on breast cancer, or any other related organization. Grants will be dispersed to charities or research projects with the most promising visions for supporting the community and advancing the cause of breast cancer research.

Sientra's U.S.-manufactured breast tissue expanders offer revolutionary, one-of-a-kind features that meet the highly individualized needs of breast reconstruction patients. Through its recent additions of the differentiated tissue expanders AlloX2® and Dermaspantm, Sientra has furthered its longstanding commitment to providing innovative options to Board-certified plastic surgeons that directly address unmet clinical needs.  

"Sientra is substantially, yet selectively expanding our product portfolio to meet a broad range of patient and surgeon needs" said Sientra Vice President of Marketing, B.J. Scheessele. "Our growing line of breast tissue expanders are purposefully designed to increase surgical control during the expansion process and address postoperative complications as early as possible, allowing them to support even the most significant and complex cases."

With its innovative, patented port and drain technology, the AlloX2® allows board-certified plastic surgeons to non-surgically address serous fluid accumulation that can lead to common postoperative complications, such as seroma. It is the first and only breast tissue expander with access to the periprosthetic space. The Dermaspantm is a trusted option designed to provide women with a soft feel and desired clinical outcomes.

About Sientra

Headquartered in Santa Barbara, California, Sientra is a medical aesthetics company committed to making a difference in patients' lives by enhancing their body image, growing their self-esteem and restoring their confidence. The Company was founded to provide greater choice to board-certified plastic surgeons and patients in need of medical aesthetics products. The Company has developed a broad portfolio of products with technologically differentiated characteristics, supported by independent laboratory testing and strong clinical trial outcomes. The Company sells its breast implants and breast tissue expanders exclusively to board-certified and board-admissible plastic surgeons and tailors its customer service offerings to their specific needs. The Company also offers a range of other aesthetic and specialty products including BIOCORNEUM®, the professional choice in scar management, and miraDry®, the only FDA cleared device to reduce underarm sweat, odor and permanently reduce hair of all colors.

For more information about Sientra, visit www.sientra.com. Find Sientra on Facebook, TwitterLinkedIn and Instagram.

Jennifer Neisse
Director of Marketing Communications

SOURCE Sientra

These press releases may also interest you

at 12:15
The truth is, obesity is getting worse worldwide. Bariatric surgical treatment, like the kind provided by Mexico Bariatric Center, is a proven long-term solution to lose weight rapidly and permanently. Weight loss surgery also helps to prevent...

at 12:15
The "Global Glaucoma Partnering 2012 to 2018" report has been added to ResearchAndMarkets.com's offering. The Global Glaucoma Partnering Terms and Agreements since 2012 report provides understanding and access to partnering deals and agreements...

at 12:15
Researchers have identified a new ALS gene: KIF5A. This important gene discovery, funded by The ALS Association through ALS Ice Bucket Challenge donations, will help researchers understand ALS disease pathways and represents a potential new ALS...

at 12:13
Researchers at Cincinnati Children's report in the journal Pediatrics a link between parents impacted by adverse childhood experiences and increased risk for delayed development of their children at age two. The...

at 12:00
Homewood Health is proud to introduce its newest inpatient treatment centre ? Homewood Ravensview, located on the Saanich Peninsula on Vancouver Island, British Columbia.   Homewood Ravensview is a world-class centre for those seeking immediate...

at 12:00
The "Global Age-related Macular Degeneration Partnering 2012 to 2018" report has been added to ResearchAndMarkets.com's offering. The Global Age-related Macular Degeneration Partnering Terms and Agreements since 2012 report provides understanding...

News published on 6 october 2017 at 06:00 and distributed by: